Biogen Declines as 2012 Forecast Misses Estimates: Boston Mover

[guest]

Biogen Idec Inc., the world's largest maker of medicines for multiple sclerosis, declined in early trading after the drugmaker forecast 2012 earnings that were less than analysts estimated.


More...

Toggle signature
||||| Mentor Group Access Now! |||||